ENO1 and myelodysplastic syndrome: Although we did not find a correlation between age and anti-ENO1 antibody levels in our adult cohorts, the control group was significantly younger than the AML and MDS groups, and this may have influenced the finding of decreased anti-ENO1 antibody levels in these patient groups (Figure 3).